Robert Langer, Director at DNIB Unwind, Inc., holds 723.42K shares in DNIB Unwind, Inc. (Ticker: BINDQ), holds ― shares in Kala Pharmaceuticals (Ticker: KALA), holds 240.02K shares in Frequency Therapeutics (Ticker: FREQ). Most recently, Robert Langer Bought ― shares of DNIB Unwind, Inc. on Aug 30, 2016 for an estimated value of 6.60K.
Robert Langer latest transaction was an Informative Buy of $6.60K.
What was Robert Langer's most profitable transaction?
Robert Langer’s most profitable transaction was an Informative Sell of NVIV stock on January 3, 2012. The return on the trade was 36.20%.
What is Robert Langer's role in DNIB Unwind, Inc.?
Robert Langer's role in DNIB Unwind, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.